HRMY
HEALTHCAREHarmony Biosciences Holdings Inc
$32.78+0.44 (+1.36%)LIVE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving HRMY Today?
No stock-specific AI insight has been generated for HRMY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$25.52$40.87
$32.78
Fundamentals
Market Cap$1.9B
P/E Ratio12.1
EPS$2.71
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.2%
Debt / Equity—
Trading
Volume750K
Avg Volume (10D)—
Shares Outstanding57.9M
HRMY News
23 articles- Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?Insider Monkey·May 9, 2026
- Should Harmony Biosciences’ Softer Q1 2026 Earnings and Upbeat Forecasts Require Action From HRMY Investors?Yahoo Finance·May 8, 2026
- Harmony Biosciences Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Sector Update: Health Care Stocks Softer Late AfternoonYahoo Finance·May 7, 2026
- Harmony Biosciences (NASDAQ: HRMY) grows Q1 sales 17% and reaffirms $1B 2026 guidanceStock Titan·May 7, 2026
- Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss EstimatesYahoo Finance·May 7, 2026
- Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic PrioritiesYahoo Finance·May 7, 2026
- Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid ChoiceYahoo Finance·May 4, 2026
- HRMY or ARGX: Which Is the Better Value Stock Right Now?Yahoo Finance·May 4, 2026
- Wall Street Analysts Think Harmony Biosciences (HRMY) Could Surge 34.81%: Read This Before Placing a BetYahoo Finance·May 4, 2026
- Assessing Harmony Biosciences (HRMY) Valuation After Recent Share Price Momentum And Pipeline ExpectationsYahoo Finance·Apr 24, 2026
- Why Harmony Biosciences (HRMY) Reaffirmed 2026 Revenue Guidance and Hired a Markets-Focused CFOYahoo Finance·Apr 24, 2026
- Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026Yahoo Finance·Apr 23, 2026
- Legend Biotech (LEGN) Moves 18.4% Higher: Will This Strength Last?Yahoo Finance·Apr 21, 2026
- 12 Small-Cap Stocks Primed for Breakouts as Earnings ApproachInvesting.com·Apr 16, 2026
- Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual MeetingYahoo Finance·Apr 16, 2026
- Harmony Biosciences Appoints Glenn Reicin as Chief Financial OfficerYahoo Finance·Apr 14, 2026
- Harmony Biosciences Eyes $1B WAKIX Runway, Teases 2026 Pipeline Catalysts at Needham ConferenceMarketbeat·Apr 14, 2026
- Harmony Biosciences Holdings (HRMY) Valuation After New COO And Board AppointmentsYahoo Finance·Apr 4, 2026
- Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its BoardYahoo Finance·Apr 2, 2026
- Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare ConferenceYahoo Finance·Mar 31, 2026
- Are Options Traders Betting on a Big Move in Harmony Biosciences Stock?Yahoo Finance·Mar 19, 2026
All 23 articles loaded
Price Data
Open$32.68
Previous Close$32.34
Day High$32.99
Day Low$32.21
52 Week High$40.87
52 Week Low$25.52
52-Week Range
$25.52$40.87
$32.78
Fundamentals
Market Cap$1.9B
P/E Ratio12.1
EPS$2.71
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.2%
Debt / Equity—
Trading
Volume750K
Avg Volume (10D)—
Shares Outstanding57.9M
About Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—